Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Filings indexed 1,303 across all filing types
Latest filing 2013-08-21 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Execution of eighth PPO agreement 2 pages 111.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated August 22, 2013, regarding Genetic Technologies Limited executing an agreement with a new Provider Network. The content focuses on a business update about expanding access to healthcare provider networks for their BREVAGen test. There are no financial statements, no mention of quarterly or annual results, no regulatory certifications, no voting results, no management changes, and no legal proceedings. The document is a corporate announcement about a business development or partnership agreement. It is not a report, transcript, or financial filing. Given the nature of the content, it fits best under the category of a general regulatory announcement or miscellaneous corporate update. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is under 5,000 characters and is a standalone announcement, not a report publication announcement or a certification.
2013-08-21 English
Share Purchase Plan documents 12 pages 719.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 20 August 2013 regarding a Share Purchase Plan (SPP) by Genetic Technologies Limited. It includes detailed information about the SPP, including the offer terms, application form, payment instructions, underwriting details, and the company's capital management program. The content focuses on fundraising activities and capital structure changes, specifically the issuance of new shares under the SPP. There are no financial statements or earnings data presented, nor is this a report or transcript. The document is not a regulatory filing or a report publication announcement but a detailed update on a capital raising event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2013-08-19 English
Cleansing notice and ASX Appendix 3B 12 pages 192.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 14 August 2013, titled 'Cleansing notice under section 708A the Corporations Act 2001 (Cth)'. It details the completion of a placement of fully paid ordinary shares by Genetic Technologies Limited, including the number of shares issued, issue price, and purpose of the issue. The document includes an Appendix 3B, which is a standard form for new issue announcements and applications for quotation of additional securities on the ASX. The content focuses on the issuance of new shares and related regulatory compliance under the Corporations Act. There are no financial statements, earnings data, management discussion, or other report content. The document is a regulatory announcement about capital raising and share issuance, not a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP).
2013-08-13 English
Fund raising update 3 pages 124.0KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 1 August 2013, detailing a capital management update and fundraising activities by Genetic Technologies Limited. It describes a private placement of shares, a proposed share purchase plan, and the proposed issuance of redeemable convertible notes. The content focuses on fundraising amounts, share issue prices, terms of convertible notes, and the intended use of proceeds. There is no financial statement or detailed financial performance data presented, nor is this a report or transcript. The document is clearly an update on capital raising activities and changes to the company's capital structure. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (over 10,000 characters) and detailed content support this classification with high confidence.
2013-07-31 English
Gtech International executes Merger Agreement 1 pag
M&A Activity Classification · 95% confidence The document is an ASX announcement dated July 30, 2013, regarding the execution of a Merger Agreement between Gtech International and Simavita Holdings. It describes the terms of the merger, including the acquisition of Simavita shares by Gtech through share issuance. The document is a public announcement of a corporate transaction, specifically a merger agreement, and does not contain detailed financial statements or comprehensive report data. It is not a full merger filing like a DEFM14A or SC TO-*, but rather an announcement of M&A activity. Therefore, the appropriate classification is 'M&A Activity' (TAR). The document length is 3608 characters, which is consistent with an announcement rather than a full report.
2013-07-29 English
Trading Halt 2 pages 85.4KB
Regulatory Filings
2013-07-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.